MARINA FAY: Open Payments
NPI 1679897011 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,136 in 37 payments from 8 companies in 2025. Trend: 2023 $1,313 · 2024 $1,236 · 2025 $1,136
Food & beverage: $1,136
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $638 |
| PFIZER INC. | 11 | $274 |
| Merz Pharmaceuticals, LLC | 2 | $66 |
| Lundbeck LLC | 2 | $65 |
| Neurelis, Inc. | 1 | $26 |
| Alnylam Pharmaceuticals Inc. | 1 | $23 |
| Eisai Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: QULIPTA, NURTEC ODT, ZAVZPRET, UBRELVY, Xeomin, VYEPTI, BOTOX, VALTOCO.
Industry payments across NY — which companies pay providers there.
